|Original language||English (US)|
|Journal||American Journal of Medicine|
|State||Published - Jun 2018|
ASJC Scopus subject areas
Access to Document
Other files and links
The Reply. / Vaduganathan, Muthiah; Qamar, Arman; Gupta, Ankur et al.In: American Journal of Medicine, Vol. 131, No. 6, 06.2018, p. e263.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - The Reply
AU - Vaduganathan, Muthiah
AU - Qamar, Arman
AU - Gupta, Ankur
AU - Bajaj, Navkaranbir
AU - Golwala, Harsh B.
AU - Pandey, Ambarish
AU - Bhatt, Deepak L.
N1 - Funding Information: Conflicts of Interest: MV and AQ are supported by the National Heart, Lung, and Blood Institute T32 postdoctoral training Grant (T32HL007604). AG and NB are supported by the National Heart, Lung, and Blood Institute T32 postdoctoral training Grant (5T32HL094301-08). DLB discloses the following relationships—Advisory Board: Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, Regado Biosciences; Board of Directors: Boston VA Research Institute, Society of Cardiovascular Patient Care; Chair: American Heart Association Quality Oversight Committee; Data Monitoring Committees: Cleveland Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, Population Health Research Institute; Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org ), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Guest Editor; Associate Editor), Population Health Research Institute (clinical trial steering committee), Slack Publications (Chief Medical Editor, Cardiology Today's Intervention), Society of Cardiovascular Patient Care (Secretary/Treasurer), WebMD (CME steering committees); Other: Clinical Cardiology (Deputy Editor), NCDR-ACTION Registry Steering Committee (Chair), VA CART Research and Publications Committee (Chair); Research Funding: Abbott, Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Regeneron, Roche, Sanofi Aventis, The Medicines Company; Royalties: Elsevier (Editor, Cardiovascular Intervention: A Companion to Braunwald's Heart Disease); Site Co-Investigator: Biotronik, Boston Scientific, St Jude Medical (now Abbott); Trustee: American College of Cardiology; Unfunded Research: FlowCo, Merck, PLx Pharma, Takeda.
PY - 2018/6
Y1 - 2018/6
UR - http://www.scopus.com/inward/record.url?scp=85047154657&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047154657&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2018.01.044
DO - 10.1016/j.amjmed.2018.01.044
M3 - Letter
C2 - 29784196
AN - SCOPUS:85047154657
SN - 0002-9343
VL - 131
SP - e263
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 6